Overexpression of Bcl-2, cytokeratins, and VEGF with downregulation of Bax, cytochrome C, caspase-3, caspase-9 and PARP may confer a survival advantage to HBP carcinomas by acquisition of an apoptosis-resistant, invasive and angiogenic phenotype. This evidence concerns the gene CASP9 and carcinoma.